How does RSCH's PS Ratio compare to its peers?

RSCH is expensive based on its Price-To-Sales Ratio (13.4x) compared to the peer average (2x).

How does RSCH's PS Ratio compare vs other companies in the ID Healthcare Industry?

RSCH is expensive based on its Price-To-Sales Ratio (13.4x) compared to the ID Healthcare industry average (2.1x).

What is RSCH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate RSCH's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of RSCH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate RSCH's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Charlie Hospital Semarang IDX:RSCH Stock Report

Last Price

Rp242.00

Market Cap

Rp641.3b

7D

0.8%

1Y

56.1%

Updated

06 Feb, 2025

Data

Company Financials

PT Charlie Hospital Semarang Tbk

IDX:RSCH Stock Report

Market Cap: Rp641.3b

RSCH Stock Overview

Operates in the private hospital business in Indonesia. More details

RSCH fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	1/6
Dividends	0/6

Rewards

Earnings have grown 27.5% per year over the past 5 years

Risk Analysis

Has less than 1 year of cash runway

Does not have a meaningful market cap (IDR641B)

Does not have meaningful revenue (IDR48B)

My Notes

Capture your thoughts, links and company narrative

PT Charlie Hospital Semarang Tbk Competitors

Kedoya Adyaraya

IDX:RSGK

Rp911.1b

Murni Sadar

IDX:MTMH

Rp1.9t

Bundamedik

IDX:BMHS

Rp2.2t

Sarana Meditama Metropolitan

IDX:SAME

Rp4.4t

Price History & Performance

Summary of share price highs, lows and changes for Charlie Hospital Semarang
Historical stock prices
Current Share Price	Rp242.00
52 Week High	Rp410.00
52 Week Low	Rp143.00
Beta	0
1 Month Change	-12.32%
3 Month Change	-33.52%
1 Year Change	56.13%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	84.73%

Recent News & Updates

Recent updates

Shareholder Returns

	RSCH	ID Healthcare	ID Market
7D	0.8%	-2.4%	-2.0%
1Y	56.1%	10.6%	2.1%

Return vs Industry: RSCH exceeded the ID Healthcare industry which returned 10.6% over the past year.

Return vs Market: RSCH exceeded the ID Market which returned 4.1% over the past year.

Price Volatility

Is RSCH's price volatile compared to industry and market?
RSCH volatility
RSCH Average Weekly Movement	4.3%
Healthcare Industry Average Movement	5.0%
Market Average Movement	5.6%
10% most volatile stocks in ID Market	13.8%
10% least volatile stocks in ID Market	2.5%

Stable Share Price: RSCH has not had significant price volatility in the past 3 months compared to the ID market.

Volatility Over Time: RSCH's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2019	216	H. Junianto	charliehospital.co.id

PT Charlie Hospital Semarang Tbk operates in the private hospital business in Indonesia. It offers medical services and support, inpatient, and medical check-up services, as well as operates wellness center. The company was founded in 2019 and is based in Kendal, Indonesia.

PT Charlie Hospital Semarang Tbk Fundamentals Summary

How do Charlie Hospital Semarang's earnings and revenue compare to its market cap?
RSCH fundamental statistics
Market cap	Rp641.30b
Earnings (TTM)	-Rp524.98m
Revenue (TTM)	Rp47.74b

13.4x

P/S Ratio

-1,222x

P/E Ratio

Is RSCH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RSCH income statement (TTM)
Revenue	Rp47.74b
Cost of Revenue	Rp33.16b
Gross Profit	Rp14.57b
Other Expenses	Rp15.10b
Earnings	-Rp524.98m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.20
Gross Margin	30.53%
Net Profit Margin	-1.10%
Debt/Equity Ratio	26.6%

How did RSCH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/06 10:05
End of Day Share Price	2025/02/06 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PT Charlie Hospital Semarang Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.